heart-letter
An FDA review of trials involving bisphosphonate drugs used to treat osteoporosis found no link between their use and any increased risk of atrial fibrillation.
The cholesterol-lowering drug ezetimbe, sold as Zetia and in combination with the statin Zocor as Vytorin, has proved no better at reducing plaque than the statin alone, and may be linked to an increased risk of cancer.
The Food and Drug Administration offers guidelines on how to properly dispose of leftover medications.
Beta blockers have helped millions of people lower their blood pressure, but for people with hypertension who do not have other cardiovascular issues or symptoms, a beta blocker might not be the most effective medication.
Bystanders using defibrillators on cardiac arrest victims double their chances of survival. A new type of defibrillator provides audio guidance to help bystanders use the device properly.
A study found that a year after a heart attack, about 20% of people were still suffering from angina. A program of cardiac rehabilitation can strengthen the heart and help eliminate angina’s pain.
Brief updates on the heart benefits of obesity surgery, a heart medication’s effect on bone health, and taking statins prior to heart surgery.
People who are at risk for heart disease may be fine for some time, until a stressful event or situation acts as a trigger for a heart attack or stroke. Even in those with heart disease, some of these triggers can be minimized or avoided.
Triglycerides contribute to atherosclerosis, usually (but not always) in combination with other factors. Triglycerides can be lowered by making lifestyle and diet changes, though some people also need a medication.
When someone has a stroke, immediate treatment is essential. The American Stroke Association says a clot-destroying drug called tPA may work for up to four and a half hours after the onset of a stroke, but should be given within an hour if possible.